# Cannabis & Metabolism: The Hidden Connection > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-and-metabolism/ > **Published:** 2025-02-26T01:10:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:18:36-04:00 > **Clinical Summary:** Science & Research · Metabolic Health Cannabis & Metabolism: How It Affects Weight, Cholesterol & Metabolic Health Medically reviewed by Dr. Benjamin Caplan, MD · Last updated August 4, 2026 A growing body of research suggests that cannabis plays a role in metabolic health, influencing cholesterol levels, body weight, insulin sensitivity, and metabolic syndrome. Cannabis […] --- Science & Research · Metabolic Health ## Cannabis & Metabolism: How It Affects Weight, Cholesterol & Metabolic Health Medically reviewed by [Dr. Benjamin Caplan](/drcaplan/), MD · Last updated August 4, 2026 A growing body of research suggests that cannabis plays a role in metabolic health, influencing cholesterol levels, body weight, insulin sensitivity, and metabolic syndrome. Cannabis is not a magic bullet for weight loss or cardiovascular health, but its impact on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) opens new avenues for understanding metabolism and improving overall wellness. [Cholesterol & Heart Health](#cholesterol)[Obesity & Metabolic Syndrome](#weight)[Blood Sugar & Diabetes](#blood-sugar)[How It Works](#how-it-works)[Cardiovascular Risk](#cardiovascular) ## How Cannabis Affects Cholesterol & Cardiovascular Health Cholesterol is essential for cell function and hormone production, but an imbalance, especially high levels of LDL, often called “bad” cholesterol, can increase the risk of heart disease. Cannabis interacts with lipid metabolism in ways that may vary based on individual physiology and dosage. LDL cholesterol contributes to plaque buildup in arteries, while HDL, or “good” cholesterol, helps remove excess cholesterol from the bloodstream. Research on cannabis and cholesterol has produced mixed results: a 2015 study on medical cannabis patients with lupus found lower total and LDL cholesterol in cannabis users compared to non-users, while other studies report no significant change. The impact on HDL is less clear,a 2013 study found lower HDL in regular users, while a 2022 study suggested a temporary increase after use. High-THC strains may elevate triglyceride levels with long-term, high-dose use. Regular cannabis users tend to have lower fasting insulin levels and improved insulin sensitivity, both of which play a role in cholesterol metabolism and heart health. Overall, cannabis may help regulate cholesterol, but effects depend on strain, dosage, and individual metabolism, more research is needed to determine long-term impacts. ## Cannabis, Obesity & Metabolic Syndrome Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes: excess belly fat, high blood pressure, high blood sugar, and abnormal cholesterol. Despite the common belief that cannabis increases appetite, studies show that regular cannabis users tend to have lower BMI and lower obesity rates than non-users, the reasons are still being explored. Regular cannabis use has been linked to lower fasting insulin levels and improved insulin response, which may reduce diabetes risk, since the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) plays a role in energy balance and fat storage. That said, a 2013 study found cannabis users had a higher percentage of visceral fat (fat surrounding organs) compared to non-users,a concern, since visceral fat increases metabolic syndrome risk. ## How Cannabis Influences Blood Sugar & Diabetes Risk A 2013 study in *Diabetes Care* found that cannabis users had 16% lower fasting insulin levels and higher insulin sensitivity, both key factors in metabolic health. Some studies suggest cannabis may lower blood sugar levels, while others indicate no effect or an increase in glucose for certain individuals. High-THC cannabis may raise blood pressure in some people, making strain selection and moderation important for those with cardiovascular concerns. Cannabis influences weight regulation, insulin sensitivity, and fat storage, but more research is needed to determine long-term effects. ## How Cannabis Supports Metabolic Health The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) plays a significant role in metabolism, appetite, and fat storage. By interacting with CB1 and [CB2 receptors](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), cannabinoids influence several metabolic processes. ### Appetite Regulation THC increases appetite via CB1 receptors, helpful for weight loss, chronic illness, or aging-related appetite decline. CBD may suppress appetite instead. ### Fat Metabolism THC may promote converting white fat into metabolically active brown fat; CBD may help reduce fat accumulation and balance lipid levels. ### Inflammation CBD’s anti-inflammatory properties may help reduce systemic inflammation linked to metabolic syndrome, and cannabis antioxidants may protect against oxidative damage. ### Insulin Sensitivity Regular users tend to have better insulin sensitivity; CBD has been studied for improving glucose metabolism, though more research is needed. [More about cannabis and metabolism →](/metabolic-endocrine-and-energy-disorders/) ## Long-Term Considerations: Cannabis & Cardiovascular Risk The relationship between [cannabis and heart health](https://cedclinic.com/cannabis-use-heart-disease-risks/) is complex. While cannabis may improve metabolic factors like insulin sensitivity and inflammation, it also has short-term effects on heart rate and blood pressure. High-THC cannabis can temporarily raise blood pressure, a concern for those with hypertension or cardiovascular disease. A 2023 study found that daily cannabis use may increase the risk of coronary artery disease by up to 30%, though occasional use did not show the same effect. Smoking cannabis carries additional cardiovascular risks due to inhaled toxins; alternative methods such as edibles, tinctures, or vaporizers may be safer. CBD may offer cardiovascular protection by reducing inflammation and oxidative stress. The effects of cannabis on heart health depend on dose, frequency, and method of use, those with heart conditions should consult a doctor before use. [Cannabis and cardiovascular risk →](/cannabis-cardiovascular-risk-impact/)  ·  [5 key insights about heart health →](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) Final thoughts: cannabis shows promise for improving cholesterol levels, regulating metabolism, and supporting insulin function, but it’s not a one-size-fits-all solution. If you struggle with weight or metabolic issues, cannabis may help regulate appetite and fat storage. If you have high cholesterol or diabetes risk, strain selection and moderation are key. If you have heart concerns, consult your doctor, as high-THC strains may temporarily raise blood pressure. ## Cannabis and GLP-1 Nausea: What’s Biologically Plausible vs. What’s Proven The endocannabinoid system is an established regulator of nausea and vomiting, CB1 activation has well-documented anti-nausea effects, which is why cannabinoids are already used clinically for chemotherapy-related nausea. Separately, experimental work shows real cross-talk between cannabinoid and incretin signaling: a randomized human crossover study found nabilone altered incretin secretion, increasing GIP and reducing post-glucose GLP-1 (Iannotti et al., 2017), and GLP-1RA-associated nausea itself appears to involve hindbrain circuitry (the NTS and area postrema) that anatomically overlaps with pathways cannabinoids are known to influence (Grill et al., 2012). Together, this is a plausible rationale for studying cannabinoid-based approaches to GLP-1-medication nausea, but direct clinical evidence that cannabis treats or prevents semaglutide- or tirzepatide-associated nausea does not yet exist. We do not claim cannabis “restores endocannabinoid tone” or “rebalances GLP-1”, that overstates the evidence. *References: Iannotti FA, et al. Incretin secretion in humans is under the influence of [cannabinoid receptors](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/). Am J Physiol Endocrinol Metab. 2017;313:E359-E366.: Rock EM, Parker LA. The Role of Cannabinoids and the Endocannabinoid System in the Treatment and Regulation of Nausea and Vomiting. Curr Top Behav Neurosci. 2026;76:339-387.: Grill HJ, et al. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists. Neuropharmacology. 2012.* ## Frequently Asked Questions ### Does cannabis raise or lower cholesterol? Research is mixed. A 2015 study found lower total and LDL cholesterol in cannabis users with lupus compared to non-users, while other studies found no significant change. The effect on HDL (“good” cholesterol) is even less clear, with studies showing conflicting results. ### Do regular cannabis users tend to have a higher or lower BMI? Despite the common belief that cannabis increases appetite and weight, studies show that regular cannabis users tend to have lower BMI and lower obesity rates than non-users. The exact reasons are still being explored. ### Can cannabis affect blood sugar and diabetes risk? A 2013 study in Diabetes Care found cannabis users had 16% lower fasting insulin levels and higher insulin sensitivity. Results on blood sugar itself are mixed, though, with some studies suggesting cannabis may lower blood sugar and others showing no effect or an increase for certain individuals. ### Does daily cannabis use raise the risk of heart disease? A 2023 study found that daily cannabis use may increase the risk of coronary artery disease by up to 30%, though occasional use did not show the same effect. High-THC cannabis can also temporarily raise blood pressure, a concern for people with hypertension or cardiovascular disease. ### Do THC and CBD affect appetite differently? Yes. THC tends to increase appetite through CB1 receptors, which can help with chronic illness or aging-related appetite decline. CBD, by contrast, may suppress appetite instead. ### Is smoking cannabis riskier for metabolic and heart health than other methods? Smoking carries additional cardiovascular risk due to inhaled toxins, so alternative methods like edibles, tinctures, or vaporizers may be safer for patients focused on metabolic and cardiovascular health. ## Ready to Learn More? Contact our team for personalized, data-driven cannabis care, or explore our dedicated Metabolic Health Program combining cannabis and GLP-1 care. [Book Your Consultation](/book/)[Explore the Metabolic Program](/metabolic/) Call (617) 500-3595 or email [help@CEDclinic.com](mailto:help@CEDclinic.com). ## References - *Diabetes Care* (2013). [PubMed](https://pubmed.ncbi.nlm.nih.gov/23530011/) - *AHA Journals* (2015). [AHA](https://www.ahajournals.org/doi/10.1161/atvb.35.suppl_1.577) - *MDPI* (2022). [MDPI](https://www.mdpi.com/2227-9717/10/8/1597) - *Frontiers in Endocrinology* (2024). [Frontiers](https://www.frontiersin.org/articles/10.3389/fendo.2024.1398462/full) - *PMC* (2022). [PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9150295/) - *CNN Health* (2023). [CNN](https://www.cnn.com/2023/02/24/health/marijuana-heart-disease-wellness/index.html) - *Stanford Medicine* (2022). [Stanford](https://med.stanford.edu/news/all-news/2022/04/marijuana-heart-disease.html) - *Healthline* (2022). [Healthline](https://www.healthline.com/health/can-weed-raise-your-cholesterol) ### Join Our Newsletter Stay updated on [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/), product recommendations, and exclusive patient insights. [**Sign up here**](https://doctorapprovedcannabis.substack.com/). --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).